Stroke Scan Inc. Company Profile

Background

Overview

Stroke Scan Inc., operating under the name Stroke Scan Plus, is a mobile ultrasound company specializing in preventive health screenings, particularly focusing on vascular diseases and internal conditions. Established in 2001 and headquartered in Katy, Texas, the company has expanded its services across the United States, offering screenings that aim to detect health issues before they become critical.

Mission and Vision

The company's mission is to provide life-saving health screenings that identify risks for strokes, abdominal aneurysms, and major abdominal organ diseases, enabling early detection and intervention. Their vision is to make preventive healthcare accessible and effective, thereby reducing the incidence of severe health conditions through proactive measures.

Primary Area of Focus

Stroke Scan Plus concentrates on mobile ultrasound services that screen for preventable diseases, including stroke risk, abdominal aortic aneurysms, thyroid abnormalities, liver conditions, kidney health, and gallbladder issues. By bringing these screenings directly to workplaces, churches, school districts, and other community organizations, they aim to reach individuals who might not otherwise seek preventive care.

Industry Significance

In the healthcare sector, Stroke Scan Plus plays a crucial role in preventive medicine by offering accessible and affordable screenings. Their services contribute to early detection, which is vital in preventing strokes and other serious health conditions, thereby potentially saving lives and reducing healthcare costs associated with late-stage disease treatments.

Key Strategic Focus

Core Objectives

Preventive Healthcare: To provide early detection of health risks, enabling timely interventions.

Accessibility: To offer mobile screening services that reach underserved and remote populations.

Education and Awareness: To educate communities about the importance of regular health screenings and proactive health management.

Specific Areas of Specialization

Stroke Risk Assessment: Screening for carotid artery blockages and plaque accumulation.

Abdominal Aortic Aneurysm Detection: Identifying abnormal enlargements in the abdominal aorta.

Thyroid, Liver, Kidney, and Gallbladder Health: Detecting abnormalities such as nodules, cysts, and other irregularities.

Key Technologies Utilized

Mobile Ultrasound Equipment: State-of-the-art ultrasound machines for accurate imaging.

Telemedicine Platforms: For remote consultations and follow-ups.

Data Management Systems: Secure platforms for storing and analyzing patient data.

Primary Markets Targeted

Corporate Wellness Programs: Offering screenings to employees as part of workplace health initiatives.

Community Organizations: Partnering with churches, schools, and civic groups to provide accessible healthcare services.

Healthcare Providers: Collaborating with clinics and hospitals to extend preventive care services.

Financials and Funding

Funding History

Specific details regarding Stroke Scan Inc.'s funding history are not publicly disclosed. The company operates as a privately held entity, focusing on self-sustained growth and expansion.

Total Funds Raised

As a privately held company, Stroke Scan Inc. has not publicly disclosed the total funds raised.

Notable Investors

Information about individual investors or venture capital involvement is not publicly available.

Intended Utilization of Capital

While specific plans are not detailed, the company likely allocates resources towards:

Expansion of Services: Increasing the number of locations and mobile units.

Technology Upgrades: Investing in advanced ultrasound equipment and data management systems.

Staff Training and Development: Ensuring high-quality service through continuous professional development.

Pipeline Development

Key Pipeline Candidates

Stroke Scan Plus primarily focuses on its existing suite of screening services rather than developing new pipeline candidates. Their approach centers on enhancing the quality and reach of current offerings.

Stages of Clinical Trials or Product Development

The company does not engage in clinical trials or product development for new medical devices. Instead, it concentrates on the application and delivery of existing ultrasound technologies for preventive health screenings.

Target Conditions

Stroke Risk: Identifying individuals at risk through carotid artery screenings.

Abdominal Aortic Aneurysms: Detecting potential aneurysms to prevent rupture.

Thyroid, Liver, Kidney, and Gallbladder Abnormalities: Screening for various internal conditions.

Relevant Timelines for Anticipated Milestones

The company focuses on continuous service improvement and expansion rather than specific product development milestones.

Technological Platform and Innovation

Proprietary Technologies

Stroke Scan Plus utilizes advanced mobile ultrasound equipment and telemedicine platforms to deliver its services. While they do not develop proprietary medical technologies, they integrate existing technologies to enhance service delivery.

Significant Scientific Methods

Ultrasound Imaging: Non-invasive imaging technique for detecting vascular and internal organ conditions.

Telemedicine: Remote consultations and follow-ups to increase accessibility.

AI-Driven Capabilities

Currently, the company does not incorporate artificial intelligence into its service offerings.

Leadership Team

Diego Ramirez – President and Founder

Diego Ramirez founded Stroke Scan Inc. in 2001. Before establishing the company, he worked in software engineering and requirements management at organizations such as Chase Bank, Zefer Corp, and Compaq Computer Corp. He holds a Bachelor of Science in Physics and a Minor in Mathematics from the University of Houston.

Competitor Profile

Market Insights and Dynamics

The preventive health screening market is growing, driven by increasing health awareness and the need for early detection of diseases. Companies like Stroke Scan Plus are well-positioned to capitalize on this trend by offering accessible and affordable screening services.

Competitor Analysis

Penumbra, Inc.: Specializes in medical devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

BrainScope Company, Inc.: Develops non-invasive assessment platforms for mild traumatic brain injury, including concussions.

Strategic Collaborations and Partnerships

Stroke Scan Plus collaborates with various community organizations, including churches, schools, and civic groups, to provide screening services. These partnerships enhance their reach and impact within communities.

Operational Insights

By focusing on mobile ultrasound services and community partnerships, Stroke Scan Plus differentiates itself from competitors that primarily offer medical devices or specialized diagnostic tools. Their operational model emphasizes accessibility and preventive care.

Strategic Opportunities and Future Directions

The company has opportunities to expand its service offerings, incorporate advanced technologies like AI for data analysis, and extend its reach to more regions, thereby increasing its impact on public health.